IL17A and Alzheimer disease: All patients with AD exhibit a type 2 and type 22 immune responses, but cytokine activation varies, including that of IL-22, IL-17, IL-9, and IFN-γ, contributing to various clinical AD subtypes (Brunner et al. 2017).